Enanta files lawsuit against Pfizer antiviral drug Paxlovid Enanta files lawsuit against Pfizer antiviral drug Paxlovid. A few days...
Drugs
'Viagra' helps esophageal cancer treatment: Clinical trials are coming soon 'Viagra' helps esophageal cancer treatment: Clinical trials are coming...
What technologies do nucleic acid drug companies such as Moderna use? What technologies do nucleic acid drug companies such...
The pesticide residues found in Häagen-Dazs vanilla ice cream in Taiwan The pesticide residues found in Haagen-Dazs vanilla ice...
More than 600 drugs for women diseases in development More than 600 drugs for women diseases in development Breast cancer,...
A common gout drug can improve survival in heart failure patients A common gout drug can improve survival in...
Novo Nordisk long-acting growth hormone meets primary endpoint of Phase 3 trials Novo Nordisk long-acting growth hormone meets primary...
Study: Infection with COVID-19 may increase risk of Parkinson's disease Study: Infection with COVID-19 may increase risk of Parkinson's...
First in the world: Innovative treatment for uterine fibroids approved by EU First in the world: Innovative treatment for...
Pfizer encountered the strongest opponent in this field of rare diseases Pfizer encountered the strongest opponent in this field...
Boston Scientific to acquire approximately 64% of MITech for approximately $230 million Boston Scientific to acquire approximately 64% of...
PD-1 immune combination therapy advances to first-line treatment of gastric cancer PD-1 immune combination therapy advances to first-line treatment of...
Roche Aβ monoclonal antibody Crenezumab failed again in clinical trials for Alzheimer's disease Roche Aβ monoclonal antibody Crenezumab failed...
UK MHRA accepts marketing application for almetinib UK MHRA accepts marketing application for almetinib. On June 14, EQRx, Inc...
Pfizer COVID-19 oral drug Paxlovid: One Phase II/III clinical trial failed Pfizer COVID-19 oral drug Paxlovid: One Phase II/III...
FDA approves Alnylam's RNAi therapy Amvuttra FDA approves Alnylam's RNAi therapy Amvuttra. On June 13, Alnylam announced that the...
Most promising breakthroughs: Drug candidate for breast cancer will start clinical trials Most promising breakthroughs: Drug candidate for breast...
More than 500 new drugs for blood diseases are in development. More than 500 new drugs for blood diseases...
Amylyx's ALS drug gets conditional approval in Canada Amylyx's ALS drug gets conditional approval in Canada. The first in...
FDA approves oral JAK inhibitor baricitinib for the treatment of alopecia areata FDA approves oral JAK inhibitor baricitinib for...
Innovative treatment for childhood brain tumors: Phase II trials of Tovorafenib is successful Innovative treatment for childhood brain tumors:...
Canadian regulator approves Albrioza to launch innovative approach to ALS Canadian regulator approves Albrioza to launch innovative approach to...
2022 Top 50 global pharmaceutical companies 2022 Top 50 global pharmaceutical companies The US Pharmaceutical Executive "Pharmaceutical Manager"...
First time: Clinical cure of solid tumor archived only by drugs First time: Clinical cure of solid tumor archived...
FDA panel unanimously backs bluebird gene therapy FDA panel unanimously backs bluebird gene therapy. On June 11, bluebird...
FGFR inhibitors demonstrate efficacy in 14 cancer types FGFR inhibitors demonstrate efficacy in 14 cancer types. Janssen, a Johnson &...
AHS 2022: AbbVie Biohaven Teva announce latest researches on migraine drugs AHS 2022: AbbVie Biohaven Teva announce latest researches on migraine drugs. ...
2008-2021: U.S. new drug listing prices rose nearly 90 times 2008-2021: U.S. new drug listing prices rose nearly 90...
Rigel shares fall 60% after Syk inhibitor fostamatinib phase III study fails Rigel shares fall 60% after Syk inhibitor...
Astellas anemia drug Evrenzo gets backing from UK NICE after FDA rejection.fter FDA rejection Astellas anemia drug Evrenzo gets...
